Table 6:

Regression analysis to determine factors significantly associated with residual breast tumor and pathologic complete response (pCR).

residual tumor versus ypT0-is		p-value	OR	CI 95%
				Inferior	Superior
cT stage	cT2-3-4		1
	cT0-1	0.079	0.766	0.569	1.031
Subtypes	Luminal A		1
	Lum B Her2−	<0,0001	0.409	0.269	0.622
	Lum B Her2+	<0,0001	0.173	0.12	0.248
	Her2+	<0,0001	0.078	0.052	0.117
	Triple Neg	<0,0001	0.172	0.123	0.239
no pCR versus pCR		p-value	OR	CI 95%
				Inferior	Superior
cT stage	cT2-3-4		1
	cT0-1	0.447	0.885	0.647	1.212
Subtypes	Luminal A		1
	Lum B Her2−	<0,0001	0.305	0.183	0.507
	Lum B Her2+	<0,0001	0.11	0.071	0.171
	Her2+	<0,0001	0.048	0.03	0.076
	Triple Neg	<0,0001	0.109	0.072	0.165
cN stage	cN0		1
	cN1	<0,0001	1.499	1.194	1.882
	cNx	0.845	0.905	0.332	2.468

Abbreviations: ypT, pathologic tumor status after NAC; cT, clinical tumor size stage; cN, clinical lymph node status.